drugset
drugset / Trial / NCT02454881

Dose Response Study of Dexmedetomidine in Orthopaedic Spine Surgery Patients

NCT02454881 ↗

Phase 4 Completed 107 enrolled Turku University Hospital University of Helsinki · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

To study the multimodal protocol combining adjunct dexmedetomidine with oxycodone in intravenous patient-controlled analgesia bolus dosing and effects in patients scheduled for posterolateral lumbar spine fusion with bilateral transpedicular screw instrumentation.

Timeline

Start
2015-06
Primary completion
2019-10-31
Completion
2020-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 2.5 ug/ml Intravenous
Comparator Dexmedetomidine Other / unclassified 5 ug/ml Intravenous
Comparator Dexmedetomidine Other / unclassified 10 ug/ml Intravenous
Comparator Oxycodone Other / unclassified 1 mg/ml Intravenous

Indications

neuropathy, painful